[Nuclear medicine and lymphoma].
Fernández de Sevilla Ribosa
Alberto
A
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D018951:Antigens, CD20 / Q000276:immunology; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use; D008223:Lymphoma / Q000000981:diagnostic imaging*; D016393:Lymphoma, B-Cell / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000532:radiotherapy; D010348:Patient Care Team; D049268:Positron-Emission Tomography; D016719:Radioimmunodetection; D016499:Radioimmunotherapy / Q000009:adverse effects; D019275:Radiopharmaceuticals / Q000009:adverse effects / Q000627:therapeutic use; D015899:Tomography, Emission-Computed, Single-Photon; D015021:Yttrium Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D018951:Antigens, CD20; D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D015021:Yttrium Radioisotopes; C422802:ibritumomab tiuxetan